Detailed Characterisation of CB2 Receptor Protein Expression in Peripheral Blood Immune Cells from Healthy Human Volunteers Using Flow Cytometry

How reliable are G-protein-coupled receptor antibodies?

(2009) Martin C. Michel et al.   NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY

CB2 cannabinoid receptor agonist JWH-015 modulates human monocyte migration through defined intracellular signaling pathways

(2008) Fabrizio Montecucco et al.   AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY

MBC94, a Conjugable Ligand for Cannabinoid CB2Receptor Imaging

(2008) Mingfeng Bai et al.   BIOCONJUGATE CHEMISTRY

Immunomodulation by Mesenchymal Stem Cells: A Potential Therapeutic Strategy for Type 1 Diabetes

(2008) R. Abdi et al.   DIABETES

Specific detection of CB1 receptors; cannabinoid CB1 receptor antibodies are not all created equal!

(2008) Natasha L. Grimsey et al.   JOURNAL OF NEUROSCIENCE METHODS

Role of CB2 receptors in neuroprotective effects of cannabinoids

(2008) Javier Fernández-Ruiz et al.   MOLECULAR AND CELLULAR ENDOCRINOLOGY

Modulation of the balance between cannabinoid CB1 and CB2 receptor activation during cerebral ischemic/reperfusion injury

(2008) M. Zhang et al.   NEUROSCIENCE

Glial expression of cannabinoid CB2 receptors and fatty acid amide hydrolase are beta amyloid–linked events in Down’s syndrome

(2008) E. Núñez et al.   NEUROSCIENCE

Cannabinoid CB2receptors: a therapeutic target for the treatment of inflammatory and neuropathic pain

(2007) J Guindon et al.   BRITISH JOURNAL OF PHARMACOLOGY

Biology and therapeutic potential of cannabinoid CB2receptor inverse agonists

(2007) C A Lunn et al.   BRITISH JOURNAL OF PHARMACOLOGY

CB2receptors in the brain: role in central immune function

(2007) G A Cabral et al.   BRITISH JOURNAL OF PHARMACOLOGY

Sch35966 is a potent, selective agonist at the peripheral cannabinoid receptor (CB2) in rodents and primates

(2007) W Gonsiorek et al.   BRITISH JOURNAL OF PHARMACOLOGY